Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hemorowin is a dietary supplement developed by Biotics Life (Biotics Lab Life Services) specifically formulated for the management of hemorrhoids (piles) and anal fissures. Marketed as part of the company's "Phytoactives" line, it is designed to support anorectal health through venotonic and vasculoprotective actions. The product typically contains a combination of flavonoids, such as micronized purified flavonoid fraction (MPFF) consisting of diosmin and hesperidin. These active ingredients work by prolonging the vasoconstrictor effect of norepinephrine on the venous wall, thereby increasing venous tone and reducing venous capacitance, distensibility, and stasis. Additionally, Hemorowin helps to improve lymphatic drainage and reduce capillary hyperpermeability and inflammation, which are key factors in the symptomatic relief of acute and chronic hemorrhoidal disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hemorowin.